KromaTiD, Inc. provides products and services for mutation detection and disease diagnosis.  KromaTiD’s patented dGH™ chromosome imaging platform enables detection of all types of chromosomal rearrangements including previously undetectable cryptic inversions.  Launched in 2013, KromaTiD’s research products and services are paving the way to a deeper understanding of genetic diseases, including cancers and developmental disorders.